161 related articles for article (PubMed ID: 31691513)
1. Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus.
Chicharro-Luna E; Pomares-Gómez FJ; Ortega-Ávila AB; Marchena-Rodríguez A; Blanquer-Gregori JFJ; Navarro-Flores E
Int Wound J; 2020 Feb; 17(1):220-227. PubMed ID: 31691513
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
3. [Neuropad test in evaluation of diabetic foot].
Vieru A; Niţă O; Graur LI; Mazilu G; Mihalache L; Popescu RM; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):90-6. PubMed ID: 23077878
[TBL] [Abstract][Full Text] [Related]
4. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
[TBL] [Abstract][Full Text] [Related]
5. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.
Madanat A; Sheshah E; Badawy el-B; Abbas A; Al-Bakheet A
Prim Care Diabetes; 2015 Aug; 9(4):304-6. PubMed ID: 25466160
[TBL] [Abstract][Full Text] [Related]
6. Peripheral neuropathy in the hands of diabetic patients with lower extremity amputations.
Pinzur MS; Labore A; Bednar M
Am J Orthop (Belle Mead NJ); 2001 Feb; 30(2):121-4. PubMed ID: 11234938
[TBL] [Abstract][Full Text] [Related]
7. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
8. Role of neuropathy and high foot pressures in diabetic foot ulceration.
Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
[TBL] [Abstract][Full Text] [Related]
9. Item reduction of the 39-item Rotterdam Diabetic Foot Study Test Battery using decision tree modelling.
Rinkel WD; van der Oest MJW; Coert JH
Diabetes Metab Res Rev; 2020 May; 36(4):e3291. PubMed ID: 31955486
[TBL] [Abstract][Full Text] [Related]
10. Atrophy of foot muscles: a measure of diabetic neuropathy.
Andersen H; Gjerstad MD; Jakobsen J
Diabetes Care; 2004 Oct; 27(10):2382-5. PubMed ID: 15451904
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ulceration risk in diabetic individuals.
Dutra LMA; Novaes MRCG; Melo MC; Veloso DLC; Faustino DL; Sousa LMS
Rev Bras Enferm; 2018; 71 Suppl 2():733-739. PubMed ID: 29791638
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
13. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.
Binns-Hall O; Selvarajah D; Sanger D; Walker J; Scott A; Tesfaye S
Diabet Med; 2018 Jul; 35(7):887-894. PubMed ID: 29608799
[TBL] [Abstract][Full Text] [Related]
14. The role of Sudoscan feet asymmetry in the diabetic foot.
Gatev T; Gateva A; Assyov Y; Nacheva S; Petrova J; Poromanski I; Kamenov Z
Prim Care Diabetes; 2020 Feb; 14(1):47-52. PubMed ID: 31153799
[TBL] [Abstract][Full Text] [Related]
15. Forefoot ulcer risk is associated with foot type in patients with diabetes and neuropathy.
Molines-Barroso RJ; Lázaro-Martínez JL; Aragón-Sánchez FJ; Álvaro-Afonso FJ; García-Morales E; García-Álvarez Y
Diabetes Res Clin Pract; 2016 Apr; 114():93-8. PubMed ID: 26810268
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
[TBL] [Abstract][Full Text] [Related]
17. Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease.
Pataky Z; Assal JP; Conne P; Vuagnat H; Golay A
Diabet Med; 2005 Jun; 22(6):762-7. PubMed ID: 15910629
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cold perception in the lower limbs: a sensitive indicator for detection of polyneuropathy in patients with type 1 diabetes mellitus.
Hyllienmark L; Jonsson B; Ekberg K; Lindström P
Diabetes Res Clin Pract; 2009 Sep; 85(3):298-303. PubMed ID: 19604594
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic foot syndrome and its risk factors in the UK.
Lauterbach S; Kostev K; Kohlmann T
J Wound Care; 2010 Aug; 19(8):333-7. PubMed ID: 20852505
[TBL] [Abstract][Full Text] [Related]
20. Insensate foot of diabetic foot ulcer can have underlying silent neuropathic pain.
Yunus YM; Rajbhandari SM
Int Wound J; 2011 Jun; 8(3):301-5. PubMed ID: 21545407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
